SAR1A expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 6.597200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
8.582000E-01
Normal-vs-Stage2
6.086600E-01
Normal-vs-Stage3
7.919400E-01
Normal-vs-Stage4
3.400800E-01
Stage1-vs-Stage2
3.276600E-01
Stage1-vs-Stage3
6.517200E-01
Stage1-vs-Stage4
2.667600E-01
Stage2-vs-Stage3
9.181600E-01
Stage2-vs-Stage4
5.006000E-01
Stage3-vs-Stage4
6.677200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
6.841200E-01
Normal-vs-AfricanAmerican
4.695000E-01
Normal-vs-Asian
7.628800E-01
Caucasian-vs-AfricanAmerican
6.046400E-01
Caucasian-vs-Asian
7.181400E-01
AfricanAmerican-vs-Asian
4.189800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
6.756400E-01
Normal-vs-Female
6.344200E-01
Male-vs-Female
9.572600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
8.446000E-01
Normal-vs-Age(41-60Yrs)
2.967200E-01
Normal-vs-Age(61-80Yrs)
8.367800E-01
Normal-vs-Age(81-100Yrs)
9.278400E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
2.004000E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
6.323000E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
8.391800E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
2.975500E-03
Age(41-60Yrs)-vs-Age(81-100Yrs)
3.600500E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
5.839200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
8.887400E-01
Normal-vs-Daily Drinker
9.029800E-01
Normal-vs-Weekly Drinker
3.045200E-01
Normal-vs-Occasional Drinker
7.093800E-01
Normal-vs-Social Drinker
4.974200E-01
Non Drinker-vs-Daily Drinker
5.824000E-01
Non Drinker-vs-Weekly Drinker
2.942200E-02
Non Drinker-vs-Occasional Drinker
3.349200E-01
Non Drinker-vs-Social Drinker
7.271600E-02
Daily Drinker-vs-Weekly Drinker
1.277250E-01
Daily Drinker-vs-Occasional Drinker
7.249400E-01
Daily Drinker-vs-Social Drinker
2.244200E-01
Weekly Drinker-vs-Occasional Drinker
1.757590E-01
Weekly Drinker-vs-Social Drinker
9.096600E-01
Occasional Drinker-vs-Social Drinker
3.499200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
9.364800E-01
Normal-vs-Grade 2
7.490200E-01
Normal-vs-Grade 3
8.163800E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
1.058060E-03
Grade 1-vs-Grade 3
5.895800E-02
Grade 1-vs-Grade 4
9.364800E-01
Grade 2-vs-Grade 3
1.300390E-01
Grade 2-vs-Grade 4
7.490200E-01
Grade 3-vs-Grade 4
8.163800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
7.719400E-01
Normal-vs-NonDiabetic
7.650000E-01
Diabetic-vs-NonDiabetic
9.622800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
3.306800E-01
Normal-vs-NoPancreatitis
7.546000E-01
Pancreatitis-vs-NoPancreatitis
3.858600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
6.677000E-01
Normal-vs-N1
6.184000E-01
N0-vs-N1
6.275600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
7.251800E-01
Normal-vs-TP53-NonMutant
8.711800E-01
TP53-Mutant-vs-TP53-NonMutant
1.042400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
